Literature DB >> 18480179

Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis.

Jiarong Chen1, Tomohiro Terada, Ken Ogasawara, Toshiya Katsura, Ken-ichi Inui.   

Abstract

During cholestasis, bile acids are mainly excreted into the urine, but adaptive renal responses to cholestasis, especially molecular mechanisms for renal secretion of bile acids, have not been well understood. Organic anion transporters (OAT1 and OAT3) are responsible for membrane transport of anionic compounds at the renal basolateral membranes. In the present study, we investigated the pathophysiological roles of OAT1 and OAT3 in terms of renal handling of bile acids. The Eisai hyperbilirubinemic rats (EHBR), mutant rats without multidrug resistance-associated protein 2, showed higher serum and urinary concentrations of bile acids, compared with Sprague-Dawley (SD) rats (wild type). The protein expression level of rat OAT3 was significantly increased in EHBR compared with SD rats, whereas the expression of rat OAT1 was unchanged. The transport activities of rat and human OAT3, but not OAT1, were markedly inhibited by various bile acids such as chenodeoxycholic acid and cholic acid. Cholic acid, glycocholic acid, and taurocholic acid, which mainly increased during cholestasis, are transported by OAT3. The plasma concentration of beta-lactam antibiotic cefotiam, a specific substrate for OAT3, was more increased in EHBR than in SD rats despite upregulation of OAT3 protein. This may be due to the competitive inhibition of cefotiam transport by bile acids via OAT3. In conclusion, the present study clearly demonstrated that OAT3 is responsible for renal secretion of bile acids during cholestasis and that the pharmacokinetic profile of OAT3 substrates may be affected by cholestasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480179     DOI: 10.1152/ajprenal.00139.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  15 in total

1.  Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.

Authors:  František Trejtnar; Jana Mandíková; Jana Kočíncová; Marie Volková
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 2.  Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-07-03       Impact factor: 4.481

Review 3.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 4.  Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis.

Authors:  Anabel Brandoni; María Herminia Hazelhoff; Romina Paula Bulacio; Adriana Mónica Torres
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

5.  Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus.

Authors:  Chirag G Patel; Ken Ogasawara; Fatemeh Akhlaghi
Journal:  Xenobiotica       Date:  2012-08-30       Impact factor: 1.908

6.  The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.

Authors:  Kevin T Bush; Wei Wu; Christina Lun; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2017-08-01       Impact factor: 5.157

Review 7.  Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis.

Authors:  Carol J Soroka; Nazzareno Ballatori; James L Boyer
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

8.  Ostα depletion protects liver from oral bile acid load.

Authors:  Carol J Soroka; Heino Velazquez; Albert Mennone; Nazzareno Ballatori; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-30       Impact factor: 4.052

9.  Effects of metabolic acidosis on expression levels of renal drug transporters.

Authors:  Arong Gaowa; Hideyuki Motohashi; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2010-12-15       Impact factor: 4.200

10.  Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Rhiannon N Hardwick; April D Lake; Anika L Dzierlenga; John D Clarke; Michael J Goedken; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2014-12-08       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.